PATENT CLAIM ANALYSIS

Application Number: 15756591
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-06
Patent Classification: ["514", "036000"]

Abstract:
Novel pseudo-trisaccharide aminoglycosides, represented by Formula I, as defined in the instant specification, designed to exhibit stop codon mutation readthrough activity, are provided. Also provided are pharmaceutical compositions containing the same, and uses thereof in the treatment of genetic diseases and disorders, such as diseases and disorders associated with stop codon mutations.

Claim (Index 6):
The compound of  claim 1 , wherein R 1  is hydrogen.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 90.0
- Lexical Diversity: 1.42857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15453990', '14866960', '13885715', '14461477', '10625059']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8030077858412299
- 35 USC 102 Novelty (BERT): 0.5156334580887805
- Combined Prediction Score: 0.7742703530659849
- Mean Citation Score: 310.667372
- Max Citation Score: 319.7449
- Similarity Product: 274.5558094864129

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test